Chris Armistead joined Ropes & Gray's corporate department in 2021 and is an associate in the mergers & acquisitions group. Chris's practice focuses on representing public and private companies in mergers, acquisitions, joint ventures, divestitures and other strategic transactions. Chris also advises clients on corporate governance matters.

Experience

  • Represent Nippon Steel, Japan's largest steelmaker, in its $14.1 billion pending acquisition of U.S. Steel.
  • Represented EMCOR Group, Inc. in its acquisition of ECM Corp.
  • Represented Heidelberg Materials in connection with the acquisition of The SEFA Group, Inc., the largest recycler of fly ash sold for use in concrete products in the United States.
  • Represented Pfizer, Inc. in its $11.6 billion acquisition of Biohaven Pharmaceuticals.
  • Represented McAfee Corp. in its $14 billion acquisition by an investor group comprised of Advent, Permira, Crosspoint Capital, Canada Pension Plan Investment Board, GIC and ADIA.

Areas of Practice